An expert panel of the Central Drugs Standard Control Organisation today recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2...
The decision was taken during an emergency meeting at the Akal Takht's secretariat, with acting Jathedar Giani Kuldip Singh Gargajj announcing the decision.
In an interview with NDTV, Maharashtra Food and Drug Administration (FDA) commissioner Tukaram Mundhe says two of the three actors have replied to the show-cause notices
Comments
Post a Comment